Aqueous extract of Ocimum canum decreases levels of fasting blood glucose and free radicals and increases antiatherogenic lipid levels in mice

Vascular Pharmacology

Volumn 39, Issue 6, 2002, Pages 273-279

  Nyarko, Alexander K ^a   Asare Anane, Henry ^b   Ofosuhene, Mark ^a   Addy, Marian E ^b   Teye, Kwesi ^a   Addo, Phyllis ^a  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

Author keywords

Cardiovascular; Diabetes mellitus; Lipids; Lipoprotein; Ocimum canum; Reactive oxygen species

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; FREE RADICAL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYL RADICAL; LIPID; LOW DENSITY LIPOPROTEIN; OCIMUM CANUM EXTRACT; PLANT EXTRACT; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIVER HOMOGENATE; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OCIMUM CANUM; PRIORITY JOURNAL;

EID: 0038648921     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00029-6     Document Type: Article

References (26)

1. Barnhart R.L., Busch S.J., Jackson R.L. Concentration-dependent antioxidant activity of probucol in low-density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation. J. Lipid Res. 30:1989;1703-1710.
2. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 26(3):2000;163-176.
3. Brandi M.L. Flavonoids: biochemical effects and therapeutic applications. Bone Miner. 19:1992;S3-S14.
4. Burstein M., Scholnick H.R., Morfin R. Rapid methods for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11:1970;583-593.
5. Castelli W.A., Garrison R.J., Wilson P.W.F., Abbot R.D., Kaousdian S., Kannel W.B. Incidence of CHD and lipoprotein cholesterol: the Framingham study. JAMA. 256:1986;2835-2838.
6. Covas M.I., Fito M., Lamuela-Raventos R.M., Sebastia N., de la Torre-Boronat C., Marrugat J. Virgin olive oil phenolic compounds: binding to human low density lipoprotein (LDL) and effect on LDL oxidation. Int. J. Clin. Pharmacol. Res. 20:2000;49-54.
7. Durrington P.N. Diabetes, hypertension and hyperlipidemia. Postgrad. Med. J. 69(Suppl. 1):1993;S18-S25.
8. Eder H.A., Bergman M. Metabolism of plasma lipids and lipoproteins. Diabetes Mellitus: Theory and Practice. 3rd ed. 1990;61-72 Medical Examination Publishing, New York.
9. Ekundayo O., Laakso I., Hiltunen R. Constituents of volatile oil from leaves of Ocimum canum Sims. Flavour Fragr. J. 4:1989;17-18.
10. Frankel E.N., Kanner J., German J.B., Parks E., Kinnsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
11. Gutherie A.H. Can total cholesterol predict CHD? Nutr. Today. 1989;8-9.
12. Hogarh, N.J., 1996. Effect of Ocimum canum aqueous extract on experimental diabetes mellitus. BSc Research Project Report, Department of Biochemistry, University of Ghana, Accra.
13. Jilial I., Devaraj S. LDL oxidation, antioxidants and atherosclerosis: a clinical biochemistry perspective. Clin. Chem. 42:1996;498-506.
14. Kuyvenhoven J.P., Meinders A.E. Oxidative stress and diabetes mellitus pathogenesis of long-term complications. Eur. J. Int. Med. 10:1999;9-19.
15. Murshed S., Sarkar S., Rokeya B., Banik N.G., Ali L., Azad Khan A.K., Nahar N., Mosihuzzaman M. Effect of Gymnema sylvestre and Momordica charantia on serum lipid of IDDM and NIDDM model rats. Diabetologia. 39(Suppl. 1):1996;A 236.
16. Nash T. Colorimetric estimate of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55:1953;416-421.
17. Nyarko A.K., Asare-Anane H., Ofosuhene M., Addy M.E. Extract of Ocimum canum lowers blood glucose and facilitates insulin release by isolated pancreatic β-islet cells. Phytomedicine. 9:2002;346-351.
18. Ostgren C.J., Lindblad U., Bog-Hansen E., Ranstam J., Melander A., Rastam L. Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. Diabetes Obes. Metab. 2:1999;105-112.
19. Owen P.L., John T. Xanthine oxidase inhibitory activity of northeastern North American plant remedies used in gout. J. Ethnopharmacol. 64:1999;149-160.
20. Pari L., Umamaheswari J. Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytother. Res. 14:2000;136-138.
21. Ross R., Harker L. Hyperlipidemia and atherosclerosis: chronic hyperlipidemia initiates and maintains lesions by endothelial cell disquamation and lipid accummulation. Science. 193:1976;1094-1100.
22. Salans L.R., Knittle J.L., Hirsch J. Obesity, glucose intolerance and diabetes mellitus. Diabetes Mellitus: Theory and Practice. 1983;469-479 Medical Examination Publishing, New York.
23. Suarez J., Herrera M.D., Marhuenda E. In vitro scavenger and antioxidant properties of hesperidine and neohesperdine dihydrochalcone. Phytomedicine. 5(6):1998;469-473.
24. Witztum J.L., Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
25. Yuting C., Rongliang Z., Zhongiang J., Yong J. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. 19:1990;19-21.
26. Zilva J.F., Pannall P.R., Mayne P.D. Clinical Chemistry in Diagnosis and Treatment. 5th ed. 1988;Sloyd-Luke Publication. pp. 61-72, 225.